Ledger.Open graph →
SEC Form D · filed February 7, 2022

Endeavor Biomedicines, Inc

Offering
$101.0M
Sold
$89.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Miguel De Los Rios · San Diego, CAExecJohn Hood · San Diego, CAExec · DirectorBernard Davitian · San Diego, CADirectorMonal C. Mehta · San Diego, CADirectorWing C. Lam · San Diego, CADirectorPatrick G. Enright · San Diego, CADirectorJonathan Gazdak · Tampa, FLDirectorMatthew P. Franz · GRAND RAPIDS, MIDirectorDaniel H. Shuart · GRAND RAPIDS, MIDirectorTodd Underwood · Portland, ORExecAndrew C. Hakim · GRAND RAPIDS, MIExec · DirectorPhilip Dickie · Grand Cayman, Cayman IslandsDirectorRaghu Saripalli · San Diego, CAExecAlex Ruggieri · Vancouver, British Columbia, CanadaDirectorRoger Richer · Vancouver, British Columbia, CanadaDirectorFrancis Macdonald · Vancouver, British Columbia, CanadaExec · DirectorBhavik M. Patel · Miami, FLDirectorKeli M. Callaghan · Miami, FLDirectorTaryn M. Naidu · Miami, FLExecRaghu Saripalli · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗